The new injectable weight-loss drug reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo.
The secret to cellular youth may depend on keeping the nucleolus – a condensed structure inside the nucleus of a cell – small, according to Weill Cornell Medicine investigators.
A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, according to researchers at Weill Cornell Medicine and University at Buffalo.
Working with week-old zebrafish larva, researchers at Weill Cornell Medicine and colleagues decoded how the connections formed by a network of neurons in the brainstem guide the fishes’ gaze.
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.
Eclectic Convergence, a yearly event hosted by Entrepreneurship at Cornell, included featured speakers, networking, a pitch contest and tabling by student businesses.
A new study by Cornell information science researchers finds that ignoring race in college admissions leads to an admitted class that is much less diverse, but with similar academic credentials to those where affirmative action is factored in.
Hospices are increasingly owned by private equity firms and publicly traded companies, but recently Weill Cornell Medicine researchers found that they performed substantially worse than hospices owned by not-for-profit agencies.
Weill Cornell Medicine and the Cornell Jeb E. Brooks School of Public Policy have established the Cornell Health Policy Center to serve as the locus for health policy impact, research and training across Cornell.
